Enhancing the Effects of Alcohol Treatment With L-Carnitine

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Alcohol Use Disorder
Interventions
DRUG

L-carnitine

L-carnitine is an endogenous precursor of acetylcholine and metabolic intermediate that facilitates the transport of acetyl groups across the mitochondrial membrane and shows promise for treating alcohol use disorder and depression.

Trial Locations (1)

02903

Brown University, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

Colorado State University

OTHER

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Brown University

OTHER